BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 12351158)

  • 1. Metabolism of heterocyclic aromatic amines by human hepatocytes and cytochrome P4501A2.
    Turesky RJ; Guengerich FP; Guillouzo A; Langouët S
    Mutat Res; 2002 Sep; 506-507():187-95. PubMed ID: 12351158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in human hepatocytes: 2-amino-3-methylimidazo[4,5-f]quinoxaline-8-carboxylic acid is a major detoxification pathway catalyzed by cytochrome P450 1A2.
    Langouët S; Welti DH; Kerriguy N; Fay LB; Huynh-Ba T; Markovic J; Guengerich FP; Guillouzo A; Turesky RJ
    Chem Res Toxicol; 2001 Feb; 14(2):211-21. PubMed ID: 11258970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive approach to the profiling of the cooked meat carcinogens 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, and their metabolites in human urine.
    Gu D; McNaughton L; Lemaster D; Lake BG; Gooderham NJ; Kadlubar FF; Turesky RJ
    Chem Res Toxicol; 2010 Apr; 23(4):788-801. PubMed ID: 20192249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rat and human hepatocytes.
    Langouët S; Paehler A; Welti DH; Kerriguy N; Guillouzo A; Turesky RJ
    Carcinogenesis; 2002 Jan; 23(1):115-22. PubMed ID: 11756232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regioselective differences in C(8)- and N-oxidation of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline by human and rat liver microsomes and cytochromes P450 1A2.
    Turesky RJ; Parisod V; Huynh-Ba T; Langouët S; Guengerich FP
    Chem Res Toxicol; 2001 Jul; 14(7):901-11. PubMed ID: 11453738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic processing and disposition of 2-amino-3-methylimidazo[4,5-f] quinoline (IQ), 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in nonhuman primates.
    Snyderwine EG; Turesky RJ; Buonarati MH; Turteltaub KW; Adamson RH
    Princess Takamatsu Symp; 1995; 23():69-77. PubMed ID: 8844797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary excretion of unmetabolized and phase II conjugates of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in humans: relationship to cytochrome P4501A2 and N-acetyltransferase activity.
    Stillwell WG; Kidd LC; Wishnok JS; Tannenbaum SR; Sinha R
    Cancer Res; 1997 Aug; 57(16):3457-64. PubMed ID: 9270013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-oxidative metabolism of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in humans: excretion of the N2-glucuronide conjugate of 2-hydroxyamino-MeIQx in urine.
    Stillwell WG; Turesky RJ; Sinha R; Tannenbaum SR
    Cancer Res; 1999 Oct; 59(20):5154-9. PubMed ID: 10537291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2.
    Turesky RJ; Constable A; Richoz J; Varga N; Markovic J; Martin MV; Guengerich FP
    Chem Res Toxicol; 1998 Aug; 11(8):925-36. PubMed ID: 9705755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of CYP1A1 and CYP1A2 to the activation of heterocyclic amines in monkeys and human.
    Edwards RJ; Murray BP; Murray S; Schulz T; Neubert D; Gant TW; Thorgeirsson SS; Boobis AR; Davies DS
    Carcinogenesis; 1994 May; 15(5):829-36. PubMed ID: 8200083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of the food-borne mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in humans.
    Turesky RJ; Garner RC; Welti DH; Richoz J; Leveson SH; Dingley KH; Turteltaub KW; Fay LB
    Chem Res Toxicol; 1998 Mar; 11(3):217-25. PubMed ID: 9544620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucuronidation of N-hydroxy heterocyclic amines by human and rat liver microsomes.
    Kaderlik KR; Mulder GJ; Turesky RJ; Lang NP; Teitel CH; Chiarelli MP; Kadlubar FF
    Carcinogenesis; 1994 Aug; 15(8):1695-701. PubMed ID: 8055651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeine Cytochrome P450 1A2 Metabolic Phenotype Does Not Predict the Metabolism of Heterocyclic Aromatic Amines in Humans.
    Turesky RJ; White KK; Wilkens LR; Le Marchand L
    Chem Res Toxicol; 2015 Aug; 28(8):1603-15. PubMed ID: 26203673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excretion of the N(2)-glucuronide conjugate of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine in urine and its relationship to CYP1A2 and NAT2 activity levels in humans.
    Stillwell WG; Sinha R; Tannenbaum SR
    Carcinogenesis; 2002 May; 23(5):831-8. PubMed ID: 12016157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic exposure to dietary heterocyclic amines in man.
    Davies DS; Gooderham NJ; Murray S; Lynch A; de la Torre R; Segura J; Boobis AR
    Princess Takamatsu Symp; 1995; 23():190-6. PubMed ID: 8844810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans.
    Boobis AR; Lynch AM; Murray S; de la Torre R; Solans A; Farré M; Segura J; Gooderham NJ; Davies DS
    Cancer Res; 1994 Jan; 54(1):89-94. PubMed ID: 8261468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of dose and cytochrome P450 induction on the metabolism and disposition of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f] quinoxaline (MeIQx) in the rat.
    Turesky RJ; Markovic J; Bracco-Hammer I; Fay LB
    Carcinogenesis; 1991 Oct; 12(10):1847-55. PubMed ID: 1934266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon.
    Turesky RJ; Lang NP; Butler MA; Teitel CH; Kadlubar FF
    Carcinogenesis; 1991 Oct; 12(10):1839-45. PubMed ID: 1934265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical methods for assessing systemic exposure to dietary heterocyclic amines in man.
    Davies DS; Gooderham NJ; Murray S; Lynch A; de la Torre R; Segura J; Boobis AR
    Arch Toxicol Suppl; 1996; 18():251-8. PubMed ID: 8678801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The contribution of N-oxidation to the metabolism of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in rat hepatocytes.
    Turesky RJ; Bracco-Hammer I; Markovic J; Richli U; Kappeler AM; Welti DH
    Chem Res Toxicol; 1990; 3(6):524-35. PubMed ID: 2103323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.